Latest Director Resignation News

Galileo Mining’s latest drilling at Norseman confirms significant palladium, platinum, and gold mineralisation over a 10km strike, underpinning plans for follow-up resource testing. The company remains well-capitalised to advance exploration.

Golden State Mining Limited has raised $1.5 million through a two-tranche placement to fund its Western Australian gold projects, while welcoming a new director and preparing for its Managing Director's departure.

Johns Lyng Group has officially been acquired by Sherwood BidCo, controlled by Pacific Equity Partners, with shareholders receiving $4.00 per share or equity in the new entity. The company will be delisted from the ASX on October 24, marking a new chapter under private ownership.

Earth’s Energy Limited has halted further exploration spending on its South Australian and Queensland geothermal assets following an independent review, shifting focus to new project opportunities. The company maintains a healthy cash position while managing its existing licences conservatively.

Equity Story Group has raised $650,000 through a strategic convertible loan led by new Non-Executive Chair Alex Brinkmeyer, signaling a pivot into property funds management. The company also announced significant board changes, including the appointment of David Nolan as Managing Director.

Platinum Asset Management has finalized its merger with L1 Capital, issuing over 1.65 billion new shares and announcing a rebrand to L1 Group Limited alongside significant board changes and share escrow arrangements.

Dalrymple Bay Infrastructure has appointed CEO Michael Riches as Managing Director, coinciding with the resignation of two non-executive directors following a significant shareholder sell-down.

CAQ Holdings Limited reported a 29.6% revenue decline and a 43.9% increase in net loss for the half-year ended June 2025, driven largely by falling investment property values and ongoing liquidity challenges.

PYC Therapeutics has restructured its Board and executive team to steer the company through pivotal clinical milestones expected by the end of 2027. The changes signal a strategic push toward late-stage development of its RNA-based drug candidates.

Golden State Mining has raised $1.5 million through a strategic share placement to fund its gold exploration projects and potential acquisitions, alongside notable board changes signaling a new chapter for the company.

RooLife Group Ltd reported a sharp 51% revenue decline to $4.62 million and a 31% increase in net loss to $2.76 million for FY2025, as it pivots towards higher-margin sectors including renewable energy and global social commerce.

Tissue Repair Ltd reported a 27.3% revenue increase to $3.22 million for FY25, driven by new distribution deals and regulatory progress, while continuing to invest heavily in clinical trials and manufacturing scale-up, resulting in a $4.24 million loss.